Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, GeneDx Holdings Corp’s stock clocked out at $19.27, down -0.10% from its previous closing price of $19.29. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 0.31 million shares were traded. WGS stock price reached its highest trading level at $20.7679 during the session, while it also had its lowest trading level at $18.8.
Ratios:
To gain a deeper understanding of WGS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 3.22. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.55.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 29 ’24 when Stueland Katherine sold 6,325 shares for $11.04 per share. The transaction valued at 69,808 led to the insider holds 75,869 shares of the business.
Feeley Kevin sold 1,104 shares of WGS for $12,185 on Apr 29 ’24. The CHIEF FINANCIAL OFFICER now owns 30,836 shares after completing the transaction at $11.04 per share. On Mar 18 ’24, another insider, Stueland Katherine, who serves as the CHIEF EXECUTIVE OFFICER of the company, sold 8,559 shares for $10.59 each. As a result, the insider received 90,661 and left with 66,698 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WGS now has a Market Capitalization of 503927840 and an Enterprise Value of 509727424. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.27 while its Price-to-Book (P/B) ratio in mrq is 2.43. Its current Enterprise Value per Revenue stands at 2.298 whereas that against EBITDA is -5.01.
Stock Price History:
The Beta on a monthly basis for WGS is 2.28, which has changed by 1.3668711 over the last 52 weeks, in comparison to a change of 0.2537824 over the same period for the S&P500. Over the past 52 weeks, WGS has reached a high of $21.71, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is 78.46%, while the 200-Day Moving Average is calculated to be 251.81%.
Shares Statistics:
It appears that WGS traded 380.37K shares on average per day over the past three months and 1297470 shares per day over the past ten days. A total of 25.98M shares are outstanding, with a floating share count of 16.27M. Insiders hold about 37.80% of the company’s shares, while institutions hold 42.38% stake in the company. Shares short for WGS as of 1713139200 were 1069120 with a Short Ratio of 2.81, compared to 1710460800 on 1052910. Therefore, it implies a Short% of Shares Outstanding of 1069120 and a Short% of Float of 11.74.
Earnings Estimates
The market rating for GeneDx Holdings Corp (WGS) is a result of the insights provided by 2.0 analysts actively involved in the assessment.On average, analysts expect EPS of -$0.32 for the current quarter, with a high estimate of -$0.32 and a low estimate of -$0.32, while EPS last year was -$1.64. The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.27 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$1.07 and -$1.27 for the fiscal current year, implying an average EPS of -$1.17. EPS for the following year is -$0.21, with 1.0 analysts recommending between -$0.21 and -$0.21.
Revenue Estimates
In the current quarter, 3 analysts expect revenue to total $59.35M. It ranges from a high estimate of $60M to a low estimate of $58.45M. As of the current estimate, GeneDx Holdings Corp’s year-ago sales were $48.71MFor the next quarter, 3 analysts are estimating revenue of $59.74M. There is a high estimate of $60.5M for the next quarter, whereas the lowest estimate is $59.03M.
A total of 3 analysts have provided revenue estimates for WGS’s current fiscal year. The highest revenue estimate was $243.4M, while the lowest revenue estimate was $241.7M, resulting in an average revenue estimate of $242.7M. In the same quarter a year ago, actual revenue was $202.57MBased on 3 analysts’ estimates, the company’s revenue will be $278.42M in the next fiscal year. The high estimate is $291.4M and the low estimate is $268.87M.
